SEARCH

SEARCH BY CITATION

References

  • 1
    Anagrelide Study Group (1992) Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. American Journal of Medicine, 92, 69 76.
  • 2
    Antiplatelet Trialists' Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. British Medial Journal, 308, 81 106.
  • 3
    Barbui, T., Finazzi, G., Dupuy, E., Kiladjian, J.J, Briere, J. (1996) Treatment strategies in essential thrombocythemia: a critical appraisal of various experiences in different centers. Leukemia and Lymphoma, 22, 149 160.
  • 4
    Bellucci, S., Janvier, M., Tobelem, G., Flandrin, G., Charpak, Y., Berger, R, Boiron, M. (1986) Essential thrombocythemias: clinical evolutionary and biological data. Cancer, 58, 2440 2447.
  • 5
    Beressi, A.H., Tefferi, A., Silverstein, M.N., Petitt, R.M, Hoagland, C.H. (1995) Outcome analysis of 34 pregnancies in women with essential thrombocythemia. Archives of Internal Medicine, 155, 1271 1222.
  • 6
    Colombi, M., Radaelli, F., Zocchi, L, Maiolo, A.T. (1991) Thrombotic and haemorrhagic complications in essential thrombocythemia: a retrospective study of 103 patients. Cancer, 67, 2926 2930.
  • 7
    Cortelazzo, S., Finazzi, G., Ruggeri, M., Galli, M., Vestri, O., Rodeghiero, F, Barbui, T. (1995) Hydroxyurea in the treatment of patients with essential thrombocythemia at high risk of thrombosis: a prospective randomized trial. New England Journal of Medicine, 322, 1132 1136.
  • 8
    Cortelazzo, S., Viero, P., Finazzi, G., D'emilio, A., Rodeghiero, F, Barbui, T. (1990) Incidence and risk factors for thrombotic complications in a historic cohort of 100 patients with essential thrombocythemia. Journal of Clinical Oncology, 8, 556 562.
  • 9
    Fenaux, P., Simon, M., Caulier, M.T., Lai, J.L., Goudemand, J, Bauters, F. (1990) Clinical course of essential thrombocythemia in 147 cases. Cancer, 66, 549 556.
  • 10
    Frezzato, M & Rodeghiero, F. (1996) Pregnancy in women with essential thrombocythaemia. British Journal of Haematology, 92, 491 493.
  • 11
    Frezzato, M., Ruggeri, M., Castaman, G, Rodeghiero, F. (1993) Polycythemia vera and essential thrombocythemia in young patients. Haematologica, 78, 11 17.
  • 12
    Frezzato, M., Tosetto, A, Rodeghiero, F. (1996) Validated questionnaire for the identification of previous personal or familial venous thromboembolism. American Journal of Epidemiology, 143, 1257 1265.
  • 13
    Gisslinger, H., Linkesch, W., Fritz, E., Ludwig, H., Chott, A, Radaskieicz, T. (1989) Long-term interferon therapy for thrombocytosis in myeloproliferative disease. Lancet, ii, 634 637.
  • 14
    Grossi, A., Rossetti, S., Vannucchi, A.M., Rafanelli, D, Rossi Ferrini, P.L. (1988) Occurrence of haemorrhagic and thrombotic events in myeloproliferative disorders. Clinical and Laboratory Haematology, 10, 165 175.
  • 15
    Hehlmann, R., Jahn, M., Baumann, B, Kopcke, W. (1988) Essential thrombocythemia: clinical characteristics and course of 61 cases. Cancer, 61, 2487 2496.
  • 16
    Kalgaard, O.M., Seem, E, Kvernebo, K. (1997) Erythromelalgia: a clinical study of 87 cases. Journal of Internal Medicine, 242, 191 197.
  • 17
    Kleinbaum, D.G., Kupper, L.L, Morgenstern, H. (1982) Epidemiologic Research. Lifetime Learning Publications, Belmont, Calif.
  • 18
    Laszlo, J. (1975) Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MDP, and hemorrhagic thrombocythemia. Seminars in Hematology, 12, 409 432.
  • 19
    Leng, G.C., Lee, A.J., Fowkes, F.G., Whiteman, M., Dunbar, J., Housley, E, Ruckley, C.V. (1996) Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. International Journal of Epidemiology, 25, 1172 1181.
  • 20
    McIntyre, K.J., Hoagland, H.C., Silverstein, M.N, Petitt, R.M. (1991) Essential thrombocythemia in young adults. Mayo Clinic Proceedings, 66, 149 154.
  • 21
    Michiels, J.J., Abels, J., Steketee, J., Van Vliet, H.H.D.M, Vuzevski, Z. (1985) Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia Annals of Internal Medicine, 102, 466 471.
  • 22
    Millard, F.E., Hunter, C.S., Anderson, M., Edelman, M.J., Kosty, M.P., Luiken, G.A, Marino, G.G. (1990) Clinical manifestations of essential thrombocythemia in young adults. American Journal of Hematology, 33, 27 31.
  • 23
    Mitus, A.J., Barbui, T., Shulman, L.N., Rosenthal, D.S., Viero, P., Cortelazzo, S, Schafer, A.I. (1990) Hemostatic complications in young patients with essential thrombocythemia. American Journal of Medicine, 88, 371 375.
  • 24
    Murphy, S., Iland, H., Rosenthal, D, Laszlo, J. (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Seminars in Hematology, 23, 177 182.
  • 25
    Murphy, S., Peterson, P., Iland, H, Laszlo, J. (1997) Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival and leukemic transition by treatment. Seminars in Hematology, 34, 29 39.
  • 26
    Nand, S., Stock, W., Godwin, J, Gross Fisher, S. (1996) Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. American Journal of Hematology, 52, 42 46.
  • 27
    Pagliaro, P., Arrigoni, L., Muggiasca, M.L., Poggio, M., Russo, U, Rossi, E. (1996) Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases. American Journal of Hematology, 53, 6 10.
  • 28
    Pardini, S., Dore, F., Murineddu, M., Bontigli, S., Longinotti, M., Grigliotti, B, Spano, B. (1993) Alpha 2b-interferon therapy and pregnancy: report of a case of essential thrombocythemia American Journal of Hematology, 43, 78 79.
  • 29
    Peto, R., Gray, R., Collins, R., Wheatly, K., Hennekens, C., Jamrozik, K., Warlow, C., Hafner, B., Thompson, E., Norton, S., Gilliland, J, Doll, R. (1988) Randomised trial of prophylactic daily aspirin in British male doctors. British Medial Journal, 296, 313 316.
  • 30
    Randi, M.L., Fabris, F, Girolami, A. (1990) Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40. Blut, 60, 233 237.
  • 31
    Ravich, R.B.M., Grunz, F.W., Reis, C.S, Thompson, I.L. (1970) The danger of surgery in uncontrolled haemorrhagic thrombocythemia. Medical Journal of Australia, i, 704 707.
  • 32
    Regev, A., Stark, P., Blickstein, D, Lahav, M. (1997) Thrombotic complications in essential thrombocythemia with relatively low platelet counts. American Journal of Hematology, 56, 168 172.
  • 33
    Rose, G.A. (1962) The diagnosis of ischemic heart pain and intermittent claudication in field surveys. Bulletin of the World Health Organization, 27, 646 658.
  • 34
    Rozman, C., Giralt, M., Feliu, E., Rubio, D, Cortes, M.T. (1991) Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer, 67, 2658 2663.
  • 35
    Schafer, A. (1984) Bleeding and thrombosis in myeloproliferative disorders. Blood, 64, 1 12.
  • 36
    Sedlacek, S.M., Curtis, J.L., Weintraub, J, Levin, J. (1986) Essential thrombocythemia and leukemic transformation. Medicine, 65, 353 364.
  • 37
    Shibata, K., Shimamoto, J.Y., Suga, K., Sano, M., Matzuzaki, M, Ymaguchi, M. (1994) Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation: a brief review of recent literature. Acta Haematologica, 91, 84 88.
  • 38
    Sterkers, Y., Preudhomme, C., Lai, J.L., Demory, J.L., Caulier, M.T., Wattel, E., Bordessoule, D., Bauters, F, Fenaux, P. (1998) Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion. Blood, 91, 616 622.
  • 39
    The ARIC Investigators (1989) The Atherosclerosis Risk In Communities (ARIC) study: design and objectives. American Journal of Epidemiology, 129, 687 702.
  • 40
    Thornley, S & Manoharan, A. (1994) Successful treatment of essential thrombocythemia with alpha interferon during pregnancy. European Journal of Hematology, 52, 63 64.
  • 41
    Van de Pette, J.E.W., Prochazka, A.V., Pearson, T.C., Singh, A.K., Dickson, E.R, Wetherley-Mein, G. (1986) Primary thrombocythaemia treated with busulphan. British Journal of Haematology, 62, 229 237.
  • 42
    Van Genderen, P.J.J & Michiels, J.J. (1993) Primary thrombocythemia: diagnosis, clinical manifestation and management. Annals of Hematology, 67, 57 62.
  • 43
    Vianelli, N., Gugliotta, L., Tura, S., Bovicelli, L, Gabrielli, A. (1994) Interferon-alpha 2a in pregnant woman with essential thrombocythemia. Blood, 83, 874 875.
  • 44
    Weinfeld, A., Swolin, B, Westin, J. (1994) Acute leukemia after hydroxyurea therapy in polycythemia vera and allied disorders: prospective study of efficacy and leukemogenicity with therapeutic implications. European Journal of Haematology, 52, 134 139.
  • 45
    Williams, J.M., Schlesinger, P, Gray, G.A. (1994) Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon. British Journal of Haematology, 88, 647 648.